| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.64B | 152.09B | 155.20B | 154.43B | 172.81B | 152.54B |
| Gross Profit | 45.45B | 45.00B | 44.94B | 42.70B | 49.28B | 42.11B |
| EBITDA | 27.31B | 23.15B | 28.55B | 29.49B | 33.62B | 26.34B |
| Net Income | 13.89B | 18.27B | 15.01B | 16.61B | 16.69B | 12.68B |
Balance Sheet | ||||||
| Total Assets | 289.67B | 307.31B | 288.10B | 290.49B | 251.35B | 245.59B |
| Cash, Cash Equivalents and Short-Term Investments | 22.51B | 24.63B | 22.24B | 22.21B | 18.51B | 17.95B |
| Total Debt | 58.26B | 52.27B | 50.30B | 48.99B | 32.38B | 39.91B |
| Total Liabilities | 101.52B | 101.21B | 99.99B | 101.02B | 80.39B | 87.28B |
| Stockholders Equity | 186.86B | 204.78B | 186.78B | 188.05B | 169.26B | 155.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.43B | 3.58B | -5.20B | 3.21B | 2.91B |
| Operating Cash Flow | 0.00 | 21.59B | 22.64B | 5.73B | 15.59B | 14.54B |
| Investing Cash Flow | 0.00 | -10.80B | -17.56B | -9.59B | -4.86B | -11.62B |
| Financing Cash Flow | 0.00 | -11.27B | -5.39B | 6.69B | -10.44B | -4.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥1.01T | 20.39 | 19.69% | 3.15% | 11.23% | 17.64% | |
70 Outperform | ¥198.09B | 10.74 | ― | 4.09% | -2.00% | 23.48% | |
70 Outperform | ¥312.29B | 12.98 | 8.05% | 3.97% | 8.66% | 49.77% | |
64 Neutral | ¥875.08B | 20.61 | 4.79% | 4.21% | -4.09% | -27.31% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥307.69B | 18.03 | ― | 5.28% | -2.31% | -1.17% | |
56 Neutral | ¥385.81B | 24.59 | -4.00% | 3.71% | -4.00% | ― |